LONDON, UK / ACCESSWIRE / April 18, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Medical Diagnostics & Research industry: ProMIS Neurosciences, Spectral Medical, GeneNews, and Sernova. Access our complimentary up-to-the-minute research reports by becoming an online member now:
www.active-investors.com/registration-sg
The S&P/TSX Composite Index progressed 52.92 points, or 0.35%, to close Tuesday's trading session at 15,353.30. The TSX Venture Exchange shaved off 4.41 points, or 0.55%, to finish at 797.55.
Moreover, the Healthcare index was down by 2.24%, closing at 82.93.
Today's stocks of interest consist of: ProMIS Neurosciences Inc. (TSX: PMN), Spectral Medical Inc. (TSX: EDT), GeneNews Ltd (TSX: GEN), and Sernova Corporation (TSXV: SVA). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:
www.active-investors.com/registration-sg
ProMIS Neurosciences Inc.
Toronto, Canada headquartered ProMIS Neurosciences Inc.'s stock finished Tuesday's session 1.27% higher at $0.40 with a total volume of 236,630 shares traded. The stock has rallied 81.82% in the previous three months and 90.48% in the past year. Shares of the Company, which discovers and develops precision medicine therapeutics for the treatment of neurodegenerative diseases, primarily Alzheimer's disease and amyotrophic lateral sclerosis, are trading above its 200-day moving average. ProMIS Neurosciences' 50-day moving average of $0.45 is above its 200-day moving average of $0.33. View the research report on PMN.TO at:
www.active-investors.com/registration-sg/?symbol=PMN
Spectral Medical Inc.
On Tuesday, shares in Toronto, Canada headquartered Spectral Medical Inc. recorded a trading volume of 10,000 shares. The stock ended the day 1.70% higher at $0.30. Shares of the Company, which focuses on the development and commercialization of theranostic treatment for septic shock in North America, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $0.37 is above its 50-day moving average of $0.34. Get the free report on EDT.TO at:
www.active-investors.com/registration-sg/?symbol=EDT
GeneNews Ltd
On Tuesday, shares in Markham, Canada-based GeneNews Ltd ended the session 5.56% lower at $0.09 with a total volume of 48,300 shares traded. Shares of the Company, which focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications, are trading below its 50-day and 200-day moving averages. Furthermore, the stock's 200-day moving average of $0.13 is greater than its 50-day moving average of $0.11. Access the most recent report coverage on GEN.TO at:
www.active-investors.com/registration-sg/?symbol=GEN
Sernova Corp.
London, Canada-based Sernova Corp.'s stock closed the day 5.80% lower at $0.33. The stock recorded a trading volume of 188,950 shares, which was above its three months average volume of 132,353 shares. Sernova's shares have gained 23.08% in the previous year. Shares of the Company, which engages in the development and commercializing of its proprietary Cell Pouch and associated technologies, are trading below their 50-day moving average. Moreover, the stock's 50-day moving average of $0.36 is greater than its 200-day moving average of $0.33. Today's complimentary report on SVA.V can be accessed at:
www.active-investors.com/registration-sg/?symbol=SVA
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
